Procore (PCOR) director Kathryn Bueker granted 4,712 RSUs in 2026

Rhea-AI Filing Summary

Procore Technologies director Kathryn Bueker received an equity award in the form of restricted stock units. She was granted 4,712 shares of common stock at no cost, bringing her direct holdings to 18,193 shares after the transaction.

The 4,712 RSUs will vest 100% on the date of Procore’s 2027 annual meeting of stockholders, or immediately before that meeting if her service ends at that time, conditioned on her continued board service through the vesting date. She has elected to defer delivery of the underlying shares until the earlier of 90 days after her service terminates or a change in control, making this a compensation-related, non-cash acquisition rather than an open-market purchase.

Insights

Equity compensation analyst

Routine director RSU grant, non-cash and service-based.

This filing shows Kathryn Bueker, a director of Procore Technologies, receiving 4,712 RSUs as part of board compensation. The award vests in full at the 2027 annual stockholder meeting, contingent on her continued service.

The transaction does not involve an open‑market buy or sell; the price per share is listed as $0.0000, indicating a grant. The deferral election delays share delivery until 90 days after service ends or upon a change in control. From an investment perspective, this is a standard, neutral governance and compensation event.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bueker Kathryn

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,712	$0.00	--

Holdings After Transaction: Common Stock — 18,193 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 4,712 shares Price per share: $0.0000 per share Shares held after transaction: 18,193 shares +2 more

5 metrics

RSU grant size 4,712 shares Restricted stock units granted on June 4, 2026

Price per share $0.0000 per share Indicates non-cash equity award

Shares held after transaction 18,193 shares Direct holdings following RSU grant

Vesting timing 2027 annual meeting 100% of RSUs vest at 2027 stockholder meeting

Deferral period 90 days Share delivery deferred until 90 days after service ends or change in control

Key Terms

restricted stock units ("RSUs"), change in control, termination of service

3 terms

restricted stock units ("RSUs") financial

"Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

change in control financial

"until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

termination of service financial

"the date that is ninety (90) days following the date of termination of service"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bueker Kathryn

(Last) (First) (Middle)

C/O PROCORE TECHNOLOGIES, INC.

6309 CARPINTERIA AVENUE

(Street)

CARPINTERIA CALIFORNIA 93013

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCORE TECHNOLOGIES, INC. [ PCOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		4,712(1)	A	$0	18,193	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control.

Remarks:

	/s/ Benjamin C. Singer, Attorney-in-Fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Procore Technologies (PCOR) director Kathryn Bueker report in this Form 4?

Kathryn Bueker reported receiving 4,712 restricted stock units of Procore Technologies common stock as a compensation grant. The award was made at no cash cost to her and increased her direct holdings to 18,193 shares after the transaction.

Is Kathryn Bueker buying or selling Procore Technologies (PCOR) shares in this filing?

She is not buying or selling in the market. The Form 4 shows an acquisition through a grant of 4,712 restricted stock units, a non‑cash equity award tied to her service as a director, rather than an open‑market purchase or sale of existing shares.

When do Kathryn Bueker’s 4,712 Procore Technologies (PCOR) RSUs vest?

All 4,712 RSUs vest 100% on the date of Procore’s 2027 annual meeting of stockholders. If her board service ends at that meeting due to not being re‑elected or not standing for re‑election, vesting occurs immediately before that meeting instead.

How many Procore Technologies (PCOR) shares does Kathryn Bueker hold after this RSU grant?

After the reported grant, Kathryn Bueker directly holds 18,193 shares of Procore Technologies common stock. This figure includes the effect of the 4,712-share restricted stock unit award disclosed in the Form 4 transaction data.

How are Kathryn Bueker’s Procore Technologies (PCOR) RSUs settled and when are shares delivered?

The 4,712 RSUs are settled in shares of common stock after vesting, but she has elected to defer actual share delivery. Shares will be delivered the earlier of 90 days after her service terminates or upon a change in control of the company.

Does this Procore Technologies (PCOR) Form 4 indicate a pre-planned trading program?

The filing describes a grant of 4,712 restricted stock units with vesting and deferral terms but does not reference any Rule 10b5‑1 trading plan. It reflects routine equity compensation, not a scheduled buying or selling program in the open market.